[Diffusion of co-tetroxazin into prostatic tissue (author's transl)].
For 2,4-diamino-5-[3,5-dimethoxy-4-(2-methoxyethoxy)]-benzylipyrimidine (tetroxoprim, TXP) and 4-amino-N-(2-pyrimidinyl)benzenesulfonamide (sulfadiazine, SDZ) tissue levels in prostate adenoma patients were 10.75 +/- 5.83 micrograms/g an 8.52 +/- 3.88 micrograms/g, respectively. In accordance with the determined plasma levels of 1.54 +/- 0.53 micrograms/ml TXP and 17.39 +/- 6.11 micrograms/ml SDZ, the prostate/plasma coefficients were found to be 8.26 (TXP) and 0.48 (SDZ).